XIENCE XPEDITION 1074275-38Recalls & reported problems
Abbott Vascular Inc. · XIENCE Xpedition LL Everolimus Eluting Coronary Stent System 2.75 mm x 38 mm / Rapid-Exchange · Class 3 · Implant
All models of XIENCE XPEDITION (41)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 08717648162282), received between Sep 27, 2019 and Sep 27, 2019 — classified as 1 injury.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
Patient problems
- Angina1
- Myocardial Infarction1
- Stenosis1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjurySep 27, 2019Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT ON (B)(6) 2019 TWO XIENCE XPEDITION STENTS, SIZES 2.75X38 AND 2.5X38 MM, WERE IMPLANTED IN THE CHRONIC TOTAL OCCLUSION IN THE LEFT ANTERIOR DESCENDING CORONARY ARTERY; ONE WAS IMPLANTED IN THE PROXIMAL TO MID LAD, THE OTHER WAS IMPLANTED IN THE DISTAL LAD. ON (B)(6) 2019 THE PATIENT HAD CHEST PAIN AND WAS FOUND TO HAVE A NON ST ELEVATION MYOCARDIAL INFARCTION. THERE WAS IN-STENT RESTENOSIS IN THE PROXIMAL TO MID LAD. THIS WAS TREATED WITH A NON-ABBOTT DRUG ELUTING STENT. IN THE DISTAL LAD, THE STENT WAS FRACTURED. THE DISTAL STENT WAS LOCATED IN AN AREA WITH A LARGE AMOUNT OF MOVEMENT BECAUSE IT IS AT A BEND. THE DISTAL STENT WAS PATENT AND DID NOT REQUIRE ANY TREATMENT. THE PATIENT CONDITION RESOLVED AND THE PATIENT WAS DISCHARGED HOME ON 9/10/2019. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: Angina; Myocardial Infarction; Stenosis
MAUDE report 9130951 ↗
Other Coronary drug-eluting stent devices
- SYNERGY™ H7493926038300Boston Scientific Corporation · Coronary drug-eluting stent8 deaths124 reports
- SYNERGY™ H7493926016300Boston Scientific Corporation · Coronary drug-eluting stent7 deaths106 reports
- SYNERGY™ H7493926020300Boston Scientific Corporation · Coronary drug-eluting stent9 deaths90 reports
- SYNERGY™ H7493926016250Boston Scientific Corporation · Coronary drug-eluting stent6 deaths82 reports
- XIENCE Sierra™ 1550350-33Abbott Vascular Inc. · Coronary drug-eluting stent1 recall32 reports
- Resolute Onyx™ RONYX30022UXMedtronic, Inc. · Coronary drug-eluting stent6 deaths76 reports
- SYNERGY™ H7493926024300Boston Scientific Corporation · Coronary drug-eluting stent3 deaths75 reports
- Resolute Onyx™ RONYX30015UXMedtronic, Inc. · Coronary drug-eluting stent3 deaths73 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page